$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
What should I pay attention to when using Genentech’s entrectinib?
2025-10-19 11:44:20
Check Details
What is the therapeutic effect of isdacrizotinib?
2025-10-19 11:44:20
Check Details
How to buy isdacrizotinib?
2025-10-19 11:44:20
Check Details
What should not be eaten while taking isdacrizotinib?
2025-10-19 11:44:20
Check Details
Machine learning model identifies stage IV EGFR+NSCLC patients who may benefit from EGFR TKI
2025-10-19 11:44:20
Check Details
Larotrectinib brings high response rate to NTRK fusion-positive lung cancer! Patients with brain metastases also benefit!
2025-10-19 11:44:20
Check Details
Quality of Life and Efficacy Data Support Lorlatinib as First-Line Therapy for ALK+NSCLC_Canghule
2025-10-19 11:44:20
Check Details
The price of Zancoda (ceritinib) is so much cheaper
2025-10-19 11:44:20
Check Details
The price of Zancoda (ceritinib) is at a discount, do you know?
2025-10-19 11:44:20
Check Details
What is the therapeutic effect of Zanda (ceritinib)
2025-10-19 11:44:20
Check Details
How much does Zancod (ceritinib) cost
2025-10-19 11:44:20
Check Details
AZD9291 purchasing channel
2025-10-19 11:44:20
Check Details
1
2
...
3783
3784
3785
3786
3787
3788
3789
...
4152
4153
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Pazopanib Shows Promise as Second-Line Therapy for Aggressive Skin Cancer
2
Managing Immunotherapy-Related Adverse Events of Tarlatamab-Imdelltra: A Guide to Dual-Specific T Cell Engager Safety
3
Almonertinib Safety Guide: Managing Adverse Reactions in NSCLC Treatment with a 3rd-Gen EGFR TKI
4
Pimitespib Storage Guidelines: Temperature, Humidity & Light Control for Home Use
5
Cemiplimab (Libtayo) Drug Information
6
Mirvetuximab Soravtansine (Elahere): FRα-Targeted ADC for Platinum-Resistant Ovarian Cancer
7
The Cornerstone Therapy for Adrenocortical Carcinoma and Global Guidelines Update
8
Trodelvy® (Sacituzumab Govitecan-hziy): A Life-Changing ADC for Advanced Cancers
9
A Revolutionary Targeted Therapy for Hematological Malignancies
10
A New Option for Advanced Renal Cell Carcinoma Treatment
11
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description:
12
Pirtobrutinib: A Novel BTK Inhibitor Offering Hope for Hematologic Cancer Patients Short Description: